HMCIB SPAC 3 (226340) - Total Liabilities

Latest as of September 2024: ₩29.73 Billion KRW ≈ $20.15 Million USD

Based on the latest financial reports, HMCIB SPAC 3 (226340) has total liabilities worth ₩29.73 Billion KRW (≈ $20.15 Million USD) as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is HMCIB SPAC 3 growing its equity to track the company's year-over-year net asset growth rate.

HMCIB SPAC 3 - Total Liabilities Trend (2015–2023)

This chart illustrates how HMCIB SPAC 3's total liabilities have evolved over time, based on quarterly financial data. See 226340 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

HMCIB SPAC 3 Competitors by Total Liabilities

The table below lists competitors of HMCIB SPAC 3 ranked by their total liabilities.

Company Country Total Liabilities
Senheng New Retail Bhd
KLSE:5305
Malaysia RM304.44 Million
Lument Finance Trust Inc
NYSE:LFT
USA $996.89 Million
Mangalam Organics Limited
NSE:MANORG
India Rs4.21 Billion
Tadmax Resources Berhad
KLSE:4022
Malaysia RM548.86 Million
Webus International Limited Ordinary Shares
NASDAQ:WETO
USA $27.44 Million
Bilici Yatirim Sanayi ve Ticaret AS
IS:BLCYT
Turkey TL910.61 Million
Havanna Holding SA
BA:HAVA
Argentina AR$74.01 Billion
Korea New Network Co. Ltd
KQ:058400
Korea ₩13.88 Billion

Liability Composition Analysis (2015–2023)

This chart breaks down HMCIB SPAC 3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 226340 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.54 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.33 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how HMCIB SPAC 3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for HMCIB SPAC 3 (2015–2023)

The table below shows the annual total liabilities of HMCIB SPAC 3 from 2015 to 2023.

Year Total Liabilities Change
2023-12-31 ₩47.65 Billion
≈ $32.29 Million
-19.20%
2022-12-31 ₩58.97 Billion
≈ $39.96 Million
-3.55%
2021-12-31 ₩61.14 Billion
≈ $41.43 Million
+178.69%
2020-12-31 ₩21.94 Billion
≈ $14.87 Million
+208.43%
2019-12-31 ₩7.11 Billion
≈ $4.82 Million
-25.38%
2018-12-31 ₩9.53 Billion
≈ $6.46 Million
+891.73%
2017-12-31 ₩961.20 Million
≈ $651.39K
+3.41%
2016-12-31 ₩929.50 Million
≈ $629.91K
+3.73%
2015-12-31 ₩896.04 Million
≈ $607.24K
--

About HMCIB SPAC 3

KQ:226340 Korea Household & Personal Products
Market Cap
$48.90 Million
₩72.16 Billion KRW
Market Cap Rank
#21988 Global
#1316 in Korea
Share Price
₩1720.00
Change (1 day)
-0.75%
52-Week Range
₩1699.00 - ₩1875.00
All Time High
₩6560.00
About

Bonne Co., Ltd. develops and supplies cosmetics in South Korea. The company offers skin care products, including whitening, wrinkle and pimple treatment, stem-cell peptide, and nano peptide products; and sun care products comprising fluids, creams, emulsions, etc. It also provides hair and body care products; makeup products, such as foundation, powder, compact, loose powder, BB cream, eye liner,… Read more